The tablets of four different brands of CBZ (200 mg
immediate release) tablets were subjected to pharmaceutical
quality control according to the British Pharmacopeia (BP)
with respect to uniformity of tablet weight and content of
active drug substance. The UV absorbance apparatus used
for the assay of the active substance was a Perkin Elmer
Lambda 16 UV 5. All batches were in compliance with the
BP.